In a clinical trial, 12 patients with SLE resistant to multiple immunosuppressive therapies received anti-CD19/BCMA CAR T cells, and all patients achieved a state of low disease activity in lupus and discontinued immunosuppressive medications [44]. Here, CD19 is linked to systemic lupus erythematosus.